Showing results (1841-1850 of 2,037) with videos related to
Sort By:
Pageof 204
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 8, 2021
Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's diseasePratishtha Chatterjee, Steve Pedrini, Nicholas J Ashton, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2008
NCCN Task Force Report: mTOR inhibition in solid tumorsRobert A Figlin, Elizabeth Brown, Andrew J Armstrong, et al.Cancer Medicine|December 26, 2025
Effects of Prior Local Therapy by Radical Prostatectomy or Radiotherapy on the Efficacy and Quality of Life of Patients Treated With Darolutamide in ARAMISMatthias Saar, Karim Fizazi, Neal D Shore, et al.Alzheimer'S Research & Therapy|October 30, 2020
Challenges and opportunities for improving the landscape for Lewy body dementia clinical trialsJennifer G Goldman, Leah K Forsberg, Bradley F Boeve, et al.The Journal of Experimental Medicine|October 29, 2024
IMPA1-derived inositol maintains stemness in castration-resistant prostate cancer via IMPDH2 activationChe-Chia Hsu, Guihua Wang, Chien-Feng Li, et al.European Urology Oncology|July 6, 2024
Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR TrialTian Zhang, Lauren Howard, Bridget F Koontz, et al.Alzheimer Disease and Associated Disorders|August 24, 2023
Predictors of Cognitive Change in Parkinson Disease: A 2-year Follow-up StudyCarmen Gasca-Salas, Sarah Duff-Canning, Eric McArthur, et al.American Heart Journal|August 17, 2019
Expanding opportunities to understand quality and outcomes of peripheral vascular interventions: The ACC NCDR PVI RegistryW Schuyler Jones, Kevin F Kennedy, Beau M Hawkins, et al.JAMA Cardiology|July 21, 2017
Comparative Outcomes After Percutaneous Coronary Intervention Among Black and White Patients Treated at US Veterans Affairs HospitalsTaisei Kobayashi, Thomas J Glorioso, Ehrin J Armstrong, et al.JCO Precision Oncology|May 11, 2026
Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel TrialAndrew J Armstrong, Fred Saad, Mototsugu Oya, et al.Pageof 204